MJ

Massarat Jan

Active Director Director DIN 10876827
DIN 10876827 First appointment Dec 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2024
Shareholding value Locked Premium profile

About Massarat Jan

Massarat Jan has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Gleen Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 10876827
Primary Designation Director
First Appointment 18 Dec 2024
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Gleen Biotech Private Limited U21000JK2024PTC016745
Director 18 Dec 2024 2024 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gleen Biotech Private Limited
Premium access

Shareholding and investment profile for Massarat Jan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Massarat Jan

Massarat Jan has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Gleen Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Massarat Jan is associated with 1 company as Director.

Massarat Jan has expertise in Technology.

Massarat Jan has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available